http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2317073-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 2004-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719a0d13a41f2f966583471a3d9261de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a8e79b2b916637630bf91f6889c176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48268f65294aa942d2f1b1ae6b9582f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf83b792f615d57681205695ae2f0388 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_228a159decea2086a222e7f51fcf2386 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29bc45acd2b8e88a425f1bfd7e0ff8ed |
| publicationDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2317073-T3 |
| titleOfInvention | BENEFIT DERIVATIVES REPLACED WITH PIRROLOPIRIDINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
| abstract | Compound of the formula ** see formula in which A means a moiety ** see formula ** in which R7 represents hydrogen, chlorine or methyl, and * represents the binding site with YY means OR 1 and R 2 means, of independent of each other, hydrogen, fluorine or chlorine, R 3 and R 4 mean, independently of each other, hydrogen or fluorine, R 5 means hydrogen, R 6 means a residue, which is selected from the group of: (C1-) alkyl C6) which is substituted with amino, hydroxy, (C1-C6) alkoxy, (C1-C6) -thio alkyl, (C1-C6) -amino, cycloalkyl (C 5-C 6) -amino, (C 1 -alkyl) -C 6) -carbonylamino, (C 1-C 6) alkoxycarbonyl, phenyl, 5- or 6-membered heteroaryl or 5- or 6-membered heterocyclyl, in which alkylamino, cycloalkylamino or phenyl, in turn, may be substituted with hydroxy, halogen, (C1-C3) alkoxy, (C1-C3) alkyl-amino or phenyl, (C1-C6) alkoxy which may be substituted with amino or (C1-C6) alkyl-amino, cyclopentyl, cyclohexyl, heterocyclyl of 5 6 members or 5 or 6 membered heterocyclyloxy, wherein cyclopentyl, cyclohexyl, heterocyclyl or heterocyclyloxy can be substituted with amino, hydroxy, (C1-C3) alkyl, oxo or benzyloxy, and phenyl, thienyl, furyl, pyrrolyl, pyrazolyl, thiazolyl , oxazolyl, imidazolyl, pyridyl, pyrimidyl or pyridazinyl, in which phenyl, thienyl, furyl, pyrrolyl, pyrazolyl, thiazolyl, oxazolyl, imidazolyl, pyridyl, pyrimidyl or pyridazinyl may be substituted with amino, hydroxy, halogen, cyano, alkyl (C 1-C 3) which, in turn, may be substituted with amino or (C 1-C 6) alkyl-amino, (C 1-C 3) alkoxy or (C 1-C 3) alkoxycarbonyl, and their salts, hydrates, salt hydrates and solvates. |
| priorityDate | 2003-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.